<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Somatostatin is a <z:chebi fb="0" ids="25905">peptide hormone</z:chebi> which inhibits the secretion of the growth hormone, and has proved to be a powerful inhibitor of exocrine pancreatic, gastric and intestinal secretion </plain></SENT>
<SENT sid="1" pm="."><plain>It was therefore used as an adjuvant therapy in the conservative treatment of two children of eight and nine years old with <z:mpath ids='MPATH_70'>fistulas</z:mpath> of the small intestine </plain></SENT>
<SENT sid="2" pm="."><plain>The first case was a colonic <z:mpath ids='MPATH_70'>fistula</z:mpath> for cecal defect, surgical intervention was carried out because treatment during 14 days with hormonal treatment after the third consecutive day of somatostatin application </plain></SENT>
<SENT sid="3" pm="."><plain>In this study the authors present their experience with somatostatin, with particular emphasis on the indications contraindications, doses and lines for administration </plain></SENT>
</text></document>